Midday Report: Organovo (ONVO) Trades Lower June 22

Equities Staff  |

Organovo Holdings Inc (NASDAQ: ONVO) shares moved 5.50%, or $0.11 per share, as on 12:05:24 est today. After Opening the Day at $2.00, 79,185 shares of Organovo exchanged hands and the stock has traded between $2.00 and $1.73.  

This year the company has a YTD change of 44.90%.

Organovo anticipates its next earnings on 2022-08-05.

For technical charts, analysis, and more on Organovo visit the company profile.

About Organovo Holdings Inc

Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's proprietary technology is being used to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Organovo's advances include cell type-specific compartments, prevalent intercellular tight junctions, and the formation of microvascular structures. Management believes these attributes can enable critical complex, multicellular disease models that can be used to develop clinically effective drugs for selected therapeutic areas.

To get more information on Organovo Holdings Inc and to follow the company's latest updates, you can visit the company's profile page here: Organovo Holdings Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content